You are here

  • Home
  • Archive
  • Volume 14, Issue 7
  • Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial

Citation Tools

Article menu
Infectious diseases
Protocol
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Snobre J, Gasana J, Ngabonziza JCS, et al
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial
BMJ Open 2024;14:e078379. doi: 10.1136/bmjopen-2023-078379